lansoprazole has been researched along with Tuberculosis in 1 studies
Lansoprazole: A 2,2,2-trifluoroethoxypyridyl derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS. Lansoprazole is a racemic mixture of (R)- and (S)-isomers.
Tuberculosis: Any of the infectious diseases of man and other animals caused by species of MYCOBACTERIUM TUBERCULOSIS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Recent in vitro and animal studies have found the proton pump inhibitor (PPI) lansoprazole to be highly active against Mycobacterium tuberculosis." | 9.24 | Lansoprazole use and tuberculosis incidence in the United Kingdom Clinical Practice Research Datalink: A population based cohort. ( Bhaskaran, K; Douglas, IJ; Langan, S; Smeeth, L; Thomas, S; Tomlinson, LA; Yates, TA, 2017) |
| "Recent in vitro and animal studies have found the proton pump inhibitor (PPI) lansoprazole to be highly active against Mycobacterium tuberculosis." | 5.24 | Lansoprazole use and tuberculosis incidence in the United Kingdom Clinical Practice Research Datalink: A population based cohort. ( Bhaskaran, K; Douglas, IJ; Langan, S; Smeeth, L; Thomas, S; Tomlinson, LA; Yates, TA, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yates, TA | 1 |
| Tomlinson, LA | 1 |
| Bhaskaran, K | 1 |
| Langan, S | 1 |
| Thomas, S | 1 |
| Smeeth, L | 1 |
| Douglas, IJ | 1 |
1 trial available for lansoprazole and Tuberculosis
| Article | Year |
|---|---|
Lansoprazole use and tuberculosis incidence in the United Kingdom Clinical Practice Research Datalink: A population based cohort.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Cohort Studies; Female; Humans; Incidence; Lansoprazole; Ma | 2017 |